小谷 祐樹 | Yuki KOTANI
@yukikotani5
集中治療専門医🥼/ICU研究の輪を広げたい🙌/留学支援したい✈️/重要文献を紹介します📝/亀田ICU @kameda_icu🏥/ Intensivist🇯🇵/Interests: vasopressors, intubation, AKI, sedation💉/ESICM SoMe member📱
ID: 1383041492265037826
https://orcid.org/0000-0002-9532-2859 16-04-2021 12:56:22
5,5K Tweet
5,5K Followers
356 Following
It’s not often such great innovation like this comes around, but remimazolam is a real game changer in anesthesia. Check out our comprehensive review led by the brilliant Juan G. Ripoll, MD 😷💉 👉🏼FREE ACCESS 🔗 authors.elsevier.com/c/1jl9~3lSIPxz… Mayo Clinic Department of Anesthesiology MayoAnesthesiaResMN Mass General Anesthesia
Had an amazing visit to Prof. Mervyn Singer and the ICU at University College London Hospital, giving a 1-hour lecture on my PhD research The Florey Grateful for the opportunity and great feedback! Prof Yugeesh Lankadeva
Rosario Losiggio, MDs Journal of Cardiothoracic and Vascular Anesthesia Giovanni Landoni, MD 小谷 祐樹 | Yuki KOTANI Jacopo D’Andria Ursoleo, MD Fabrizio Monaco, MD Alessandro Belletti Gianluca Paternoster Matteo Borello San Raffaele Anesthesia and Intensive Care This is definitely worth a dedicated mRCT powered on death
Rosario Losiggio, MDs Journal of Cardiothoracic and Vascular Anesthesia Giovanni Landoni, MD 小谷 祐樹 | Yuki KOTANI Jacopo D’Andria Ursoleo, MD Fabrizio Monaco, MD Alessandro Belletti Gianluca Paternoster Matteo Borello San Raffaele Anesthesia and Intensive Care Domenico Pontillo Alessandro Pruna, MD 6000-10000 probably (frequentist, depending on proportions). But what about a Bayesian trial with a informative prior based upon the SR/MA? Suppose you started at 80% probability that HR <1. centered around 0.7. Run until >97.5/99% or <60%. Arthur Albuquerque
A narrative review on AKI biomarkers I wonder how the upcoming KDIGO revision will incorporate these functional and damage/stress biomarkers🤔 Marlies Ostermann Matthieu Legrand John Kellum ANNALS OF INTENSIVE CARE - AIC 🔓rdcu.be/dT4iH